Orbimed Advisors Trims $125 After Breakout Year in Biotech
A major biotech stake shift signals evolving risk appetite. We break down the $125 million trim by ORBIMED Advisors, ...
Decide which is better for your needs: credit card points or cash back. Evaluate the benefits to optimize your rewards strategy.
27,103 articlesA major biotech stake shift signals evolving risk appetite. We break down the $125 million trim by ORBIMED Advisors, ...
Greg Abel delivers his first annual letter as Berkshire’s CEO, outlining continuity after a $4.5 billion write-down o...
A Friday deadline intensifies a clash between Anthropic and the Pentagon over how its Claude AI models may be used by...
The FDA is piloting cash bonuses to reward reviewers who finish drug evaluations faster while preserving scientific r...
Nvidia sits at a potential turning point, guided by a history of cycles tied to AI and data centers. This article unf...
Global markets weigh climate risk as a likely Super El Niño could boost temperatures in 2027. This stock trader’s gui...
A tight group of U.S.-listed power chip stocks built around silicon carbide and GaN technologies are rallying as elec...
A dramatic rise in sandisk stock skyrocketed 857% in the first half of 2026 captured investors’ attention. This artic...
Bitcoin, Ethereum, and Solana jumped as analysts flagged a pause in the '10 a.m. dump' after a Jane Street lawsuit, m...
As tensions in the Middle East escalate, the IEA warns the iran war’s effect worse for energy markets than past shock...
California’s CEQA exemption is speeding residential projects, yet fault lines surface as opponents deploy new delay t...
Brent crude sits around $101 per barrel on June 3, 2026, as markets weigh supply risks, demand patterns, and policy m...